AEON

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

AEON Biopharma, Inc.

NYSE MKT | AEON

0.76

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 18, 2025)

$8.71M

Market Cap

-

P/E Ratio

-13.91

EPS

$115.57

52 Week High

$0.37

52 Week Low

HEALTHCARE

Sector

AEON Chart

Recent Chart
Price Action

AEON Technicals

Tags:

AEON Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income $73M
Selling General And Administrative $14M
Research And Development $14M
Operating Expenses -$73M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $97K
Income Before Tax $42M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $42M
Comprehensive Income Net Of Tax -
Ebit -$28M
Ebitda -$28M
Net Income $42M

Revenue & Profitability

Earnings Performance

AEON Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $3.1M
Total Current Assets $1.6M
Cash And Cash Equivalents At Carrying Value $13K
Cash And Short Term Investments $13K
Inventory -
Current Net Receivables -
Total Non Current Assets $1.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.6M
Other Non Current Assets -
Total Liabilities $32M
Total Current Liabilities $14M
Current Accounts Payable $5.9M
Deferred Revenue -
Current Debt -
Short Term Debt $121K
Total Non Current Liabilities $18M
Capital Lease Obligations $1.3M
Long Term Debt $12M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $13M
Other Current Liabilities $7.5M
Other Non Current Liabilities $3.5M
Total Shareholder Equity -$29M
Treasury Stock -
Retained Earnings -$432M
Common Stock $4K
Common Stock Shares Outstanding $8K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$20M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $97K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $15M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $42M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income $73M
Selling General And Administrative $14M
Research And Development $14M
Operating Expenses -$73M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $97K
Income Before Tax $42M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $42M
Comprehensive Income Net Of Tax -
Ebit -$28M
Ebitda -$28M
Net Income $42M

AEON Profile

AEON Biopharma, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

AEON Biopharma, Inc. is an innovative biopharmaceutical company based in Newport Beach, California, specializing in the development of botulinum toxin products aimed at addressing a range of debilitating medical conditions. The company's robust pipeline emphasizes the therapeutic potential of its proprietary formulations, positioning AEON as a key player in the neuromodulators market. With a commitment to advancing treatment options and improving patient outcomes, AEON is strategically positioned to capitalize on the growing demand for effective interventions in both aesthetic and therapeutic applications.

ADAP
+108.91%
$0.16
INTC
+23.05%
$30.64
DVLT
+21.00%
$0.41
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
SNAP
+6.32%
$8.49
ATCH
-28.08%
$1.16
GPUS
+23.87%
$0.51
BITF
+4.42%
$3.18
LASE
+69.10%
$4.73
PLUG
+4.86%
$2.09
CDLX
+109.79%
$3.00
RAYA
+35.57%
$0.06
RGTI
+12.50%
$24.74
AAL
+0.80%
$12.58
APVO
+38.96%
$1.95
LYFT
+13.12%
$22.84
GRAB
+4.09%
$6.35
TSLA
-2.11%
$416.85
MARA
+6.68%
$18.50
SOUN
+3.47%
$15.64
NEHC
-4.00%
$0.45
AMD
-0.81%
$157.85
NIO
-1.14%
$7.36
FAAS
-10.53%
$0.08
ETNB
+85.08%
$14.95
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
YAAS
+14.04%
$0.07
QBTS
+8.31%
$24.41
BINI
-16.93%
$0.05
BMNR
+4.78%
$59.80
PLTR
+4.78%
$176.38
TNMG
-0.27%
$0.32
SOFI
+3.88%
$28.19
CLSK
+16.87%
$13.37
QS
+18.12%
$12.11
DNN
+0.59%
$2.55
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
BTG
0.00%
$4.33
TLRY
+5.88%
$1.26
RR
+12.81%
$4.49
AVGO
-3.84%
$346.17
BBD
-1.05%
$3.27
AAPL
-0.46%
$237.88
IONQ
+1.22%
$66.23
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
QUBT
+4.06%
$18.43
ADD
-25.47%
$0.05
HIMS
+11.55%
$56.17
CIFR
-4.28%
$11.85
AMZN
-0.16%
$231.23
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
ACHR
+2.94%
$9.26
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
KDLY
+4.19%
$1.49
WBD
+3.44%
$18.60
PFE
+0.35%
$24.13
RZLV
-3.26%
$7.11
WULF
-1.58%
$11.17
ABEV
-2.45%
$2.30
RIG
-2.01%
$3.40
HBAN
+1.88%
$17.87
IXHL
+2.29%
$0.54
IONZ
-4.37%
$4.59
NVNI
+11.78%
$0.90
NOK
+1.38%
$4.76
ITUB
+1.82%
$7.27
HOOD
+2.24%
$121.29
BTE
-2.29%
$2.54
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
KEY
+2.16%
$19.11
MU
+5.56%
$168.89
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
ORIS
+11.11%
$0.15
VALE
-0.32%
$10.84
KVUE
-1.36%
$18.09
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
PBM
+42.47%
$5.30
CAN
+1.23%
$0.81
LDI
-9.86%
$4.11
ADAP
+108.91%
$0.16
INTC
+23.05%
$30.64
DVLT
+21.00%
$0.41
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
SNAP
+6.32%
$8.49
ATCH
-28.08%
$1.16
GPUS
+23.87%
$0.51
BITF
+4.42%
$3.18
LASE
+69.10%
$4.73
PLUG
+4.86%
$2.09
CDLX
+109.79%
$3.00
RAYA
+35.57%
$0.06
RGTI
+12.50%
$24.74
AAL
+0.80%
$12.58
APVO
+38.96%
$1.95
LYFT
+13.12%
$22.84
GRAB
+4.09%
$6.35
TSLA
-2.11%
$416.85
MARA
+6.68%
$18.50
SOUN
+3.47%
$15.64
NEHC
-4.00%
$0.45
AMD
-0.81%
$157.85
NIO
-1.14%
$7.36
FAAS
-10.53%
$0.08
ETNB
+85.08%
$14.95
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
YAAS
+14.04%
$0.07
QBTS
+8.31%
$24.41
BINI
-16.93%
$0.05
BMNR
+4.78%
$59.80
PLTR
+4.78%
$176.38
TNMG
-0.27%
$0.32
SOFI
+3.88%
$28.19
CLSK
+16.87%
$13.37
QS
+18.12%
$12.11
DNN
+0.59%
$2.55
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
BTG
0.00%
$4.33
TLRY
+5.88%
$1.26
RR
+12.81%
$4.49
AVGO
-3.84%
$346.17
BBD
-1.05%
$3.27
AAPL
-0.46%
$237.88
IONQ
+1.22%
$66.23
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
QUBT
+4.06%
$18.43
ADD
-25.47%
$0.05
HIMS
+11.55%
$56.17
CIFR
-4.28%
$11.85
AMZN
-0.16%
$231.23
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
ACHR
+2.94%
$9.26
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
KDLY
+4.19%
$1.49
WBD
+3.44%
$18.60
PFE
+0.35%
$24.13
RZLV
-3.26%
$7.11
WULF
-1.58%
$11.17
ABEV
-2.45%
$2.30
RIG
-2.01%
$3.40
HBAN
+1.88%
$17.87
IXHL
+2.29%
$0.54
IONZ
-4.37%
$4.59
NVNI
+11.78%
$0.90
NOK
+1.38%
$4.76
ITUB
+1.82%
$7.27
HOOD
+2.24%
$121.29
BTE
-2.29%
$2.54
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
KEY
+2.16%
$19.11
MU
+5.56%
$168.89
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
ORIS
+11.11%
$0.15
VALE
-0.32%
$10.84
KVUE
-1.36%
$18.09
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
PBM
+42.47%
$5.30
CAN
+1.23%
$0.81
LDI
-9.86%
$4.11
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.